IPHA Latest Press Releases

-- October 21, 2026 --

Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference Business Wire 1:00 AM

-- October 20, 2026 --

Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update Business Wire 1:00 AM

-- September 17, 2026 --

Innate Pharma Reports First Half 2026 Business Update and Financial Results Business Wire 1:00 AM

-- September 16, 2026 --

Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions Business Wire 4:00 PM

-- September 10, 2026 --

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update Business Wire 1:00 AM

-- September 2, 2026 --

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Business Wire 1:00 AM

-- August 14, 2026 --

Innate Pharma Announces Conference Call and Webcast Business Wire 5:30 AM

-- August 10, 2026 --

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma PRNewswire 2:33 AM

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer Business Wire 2:30 AM

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma Business Wire 2:00 AM

-- July 23, 2026 --

Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference Business Wire 1:00 AM

-- July 21, 2026 --

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC) Business Wire 1:00 AM

Market Data Delayed 15 Minutes